Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

4.40
Delayed Data
As of Feb 17
 +0.12 / +2.80%
Today’s Change
3.32
Today|||52-Week Range
9.83
+13.40%
Year-to-Date
SECTOR
Consumer Services
INDUSTRY
Other Consumer Services
MARKET CAP
$36.9M

Company Description

TapImmune, Inc. engages in developing immunotherapies for cancers and infectious diseases designed to target tumors and metastatic disease. It develops vaccines for breast cancer, colorectal cancer, ovarian cancer and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL.

Contact Information

TapImmune, Inc.
50 North Laura Street
Jacksonville Florida 32202
P:(904) 516-5436
Investor Relations:
(206) 504-7267

Employees

Shareholders

Individual stakeholders0.37%
Mutual fund holders--
Other institutional--

Top Executives

Glynn WilsonChairman, CEO, Secretary & CAO
John N. BonfiglioPresident, Chief Operating Officer & Director
Michael J. LoiaconoCFO, Secretary, Treasurer & CAO
Elizabeth DonnellyAdministration Director
Mark ReddishDirector & Vice President-Development